Total Payments
$3,867
2024 Payments
$15.12
Companies
35
Transactions
301
Medicare Patients
5,748
Medicare Billing
$514,803
Payment Breakdown by Category
Food & Beverage$3,775 (97.6%)
Education$91.61 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,775 | 298 | 97.6% |
| Education | $91.61 | 3 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $626.26 | 63 | $0 (2021) |
| Novo Nordisk Inc | $510.15 | 39 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $451.57 | 35 | $0 (2022) |
| GlaxoSmithKline, LLC. | $316.51 | 26 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $289.24 | 22 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $218.85 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $199.04 | 12 | $0 (2019) |
| Astellas Pharma US Inc | $158.92 | 7 | $0 (2019) |
| Mylan Specialty L.P. | $152.98 | 11 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $114.09 | 13 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.12 | 1 | ABBVIE INC. ($15.12) |
| 2023 | $67.50 | 4 | Novo Nordisk Inc ($45.41) |
| 2022 | $136.14 | 9 | RedHill Biopharma Inc. ($25.22) |
| 2021 | $268.32 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($79.69) |
| 2020 | $338.51 | 26 | Novo Nordisk Inc ($123.49) |
| 2019 | $814.08 | 60 | Novo Nordisk Inc ($160.91) |
| 2018 | $1,088 | 90 | PFIZER INC. ($217.28) |
| 2017 | $1,140 | 93 | SANOFI-AVENTIS U.S. LLC ($185.58) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 2 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/25/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular | ||||||
| 02/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes | ||||||
| 02/11/2021 | PFIZER INC. | PREMARIN (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: WOMENS HEALTH | ||||||
| 02/11/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes Care | ||||||
| 02/02/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Diabetes | ||||||
| 01/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/17/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Obesity | ||||||
| 12/17/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Cardiovascular | ||||||
| 12/08/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Diabetes Care | ||||||
| 12/08/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: Diabetes | ||||||
| 12/01/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/10/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/20/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/06/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 09/24/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: Diabetes | ||||||
| 09/23/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/15/2020 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $12.00 | General |
| Category: GI | ||||||
| 08/27/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 08/20/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Diabetes | ||||||
| 08/18/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular | ||||||
| 08/11/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: Diabetes | ||||||
| 07/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,193 | 2,178 | $297,249 | $107,981 |
| 2022 | 20 | 1,438 | 2,978 | $389,994 | $143,033 |
| 2021 | 26 | 1,568 | 3,079 | $405,112 | $150,192 |
| 2020 | 19 | 1,549 | 2,558 | $306,380 | $113,597 |
Total Patients
5,748
Total Services
10,793
Medicare Billing
$514,803
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 290 | 703 | $169,029 | $56,344 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 324 | $54,711 | $18,067 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 95 | 95 | $20,125 | $11,401 | 56.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 45 | 45 | $14,139 | $6,934 | 49.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 41 | 41 | $6,556 | $3,178 | 48.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 53 | 62 | $6,380 | $2,422 | 38.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 58 | 77 | $6,930 | $2,415 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,802 | $2,030 | 26.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 81 | 178 | $4,621 | $1,541 | 33.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 31 | 45 | $1,829 | $1,203 | 65.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 15 | $792.30 | $575.10 | 72.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 16 | 16 | $1,036 | $475.80 | 45.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 28 | 29 | $959.90 | $454.16 | 47.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 23 | 24 | $793.44 | $372.60 | 47.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 51 | 73 | $474.50 | $264.26 | 55.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 44 | 58 | $403.68 | $122.70 | 30.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 40 | 238 | $247.52 | $85.95 | 34.7% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 15 | 26 | $260.00 | $58.28 | 22.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 33 | 93 | $111.60 | $26.21 | 23.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 11 | $48.62 | $11.14 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 343 | 953 | $229,139 | $76,346 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 238 | 468 | $79,026 | $29,450 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $14,617 | $8,233 | 56.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 104 | 171 | $15,390 | $6,855 | 44.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 44 | 44 | $13,825 | $6,737 | 48.7% |
About Dr. Degail Hadley, D.O
Dr. Degail Hadley, D.O is a Family Medicine healthcare provider based in Cleveland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1720216955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Degail Hadley, D.O has received a total of $3,867 in payments from pharmaceutical and medical device companies, with $15.12 received in 2024. These payments were reported across 301 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,775).
As a Medicare-enrolled provider, Hadley has provided services to 5,748 Medicare beneficiaries, totaling 10,793 services with total Medicare billing of $514,803. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Cleveland, MS
- Active Since 06/25/2009
- Last Updated 03/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720216955
Products in Payments
- Ozempic (Drug) $256.71
- ENTRESTO (Drug) $199.04
- SOLIQUA (Drug) $192.09
- BEVESPI AEROSPHERE (Drug) $185.51
- JARDIANCE (Drug) $171.69
- CHANTIX (Drug) $152.89
- TOVIAZ (Drug) $151.94
- ANORO (Drug) $140.72
- VIAGRA (Drug) $133.42
- BREO (Drug) $122.34
- Victoza (Drug) $103.63
- FARXIGA (Drug) $99.17
- Yupelri (Drug) $86.31
- Myrbetriq (Drug) $80.84
- Tresiba (Drug) $76.41
- SYMBICORT (Drug) $71.58
- Prolia (Biological) $65.65
- JANUVIA (Drug) $63.86
- LYRICA (Drug) $60.45
- PRALUENT (Drug) $58.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cleveland
Dominic King, D.o, D.O
Family Medicine — Payments: $337,674
Family Medicine $337,674
Jeannette Potts, Md, MD
Family Medicine — Payments: $30,044
Family Medicine $30,044
Meaghan Combs, Md, MD
Family Medicine — Payments: $25,727
Family Medicine $25,727
George Stokes, Md, MD
Family Medicine — Payments: $18,678
Family Medicine $18,678
Dr. Charles Brock, M.d, M.D
Family Medicine — Payments: $9,519
Family Medicine $9,519
Mr. Cecil Breetzke, Md, MD
Family Medicine — Payments: $9,499
Family Medicine $9,499